Sign Up to like & get
recommendations!
2
Published in 2022 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2527
Abstract: The SLCO1B1 genotype is known to influence patient adherence to statin therapy, in part by increasing the risk for statināassociated musculoskeletal symptoms (SAMSs). The SLCO1B1*5 allele has previously been associated with simvastatin discontinuation and SAMSs.…
read more here.
Keywords:
atorvastatin discontinuation;
muscle;
routine care;
discontinuation ... See more keywords